ArticleInternational journal of clinical oncology2011
An inconspicuous fallopian-tube carcinoma clinically manifested as a rectovaginal septal tumor: a pitfall for diagnosis and treatment.
Article in International journal of clinical oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report an unusual metastasis of an inconspicuous fallopian-tube carcinoma to the rectovaginal septum in a 67-year-old woman. The 4-cm tumor of serous adenocarcinoma was identified in the rectovaginal space with intact vaginal and rectal mucosa. The patient underwent an abdominoperineal resection with adjacent rectum and the bilateral uterine annexes, which were macroscopically intact. Unexpectedly, invasive and intraepithelial serous adenocarcinoma in fallopian-tube fimbria was microscopically observed, suggesting that the fallopian fimbria was the origin of the rectovaginal septum tumor. The clonality of these two tumors was confirmed by the presence of an identical single nucleotide point mutation in TP53. The patient received six cycles of adjuvant paclitaxel and carboplatin combination chemotherapy. There was no sign of recurrence after 17 months of treatment. This case study demonstrates that the fallopian-tube carcinoma, which exhibited minimal growth in the primary site, has the potential to metastasize to the retroperitoneal space and suggests that the fallopian-tube fimbria must be closely examined in cases of adenocarcinoma of unknown origin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.